Home/Belenos Biosciences/Glenn Rosen, M.D.

GR

Glenn Rosen, M.D.

Chief Translational Officer & Co-Founder

Belenos Biosciences

Therapeutic Areas

Asthma Atopic Dermatitis COPD Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)Chronic Spontaneous Urticaria (CSU)Food Allergy Scleroderma

Belenos Biosciences Pipeline

Drug	Indication	Phase
BEL512	Asthma, Atopic Dermatitis, COPD, CRSwNP, CSU	IND Enabling
BEL536	Atopic Dermatitis, Food Allergy, Scleroderma	IND Enabling

Leadership Team at Belenos Biosciences

Donnie McGrath, M.D., M.P.H.

CEO & Co-Founder

Megan Dow, Ph.D.

COO & Co-Founder

Tania Dimitrova, M.B.A.

CFO & Co-Founder

Nick Vrolijk, Ph.D.

Head of Manufacturing

Head of Clinical Operations

View full Belenos Biosciences profile